全文获取类型
收费全文 | 1880篇 |
免费 | 99篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 94篇 |
妇产科学 | 17篇 |
基础医学 | 190篇 |
口腔科学 | 32篇 |
临床医学 | 179篇 |
内科学 | 464篇 |
皮肤病学 | 54篇 |
神经病学 | 82篇 |
特种医学 | 371篇 |
外国民族医学 | 1篇 |
外科学 | 170篇 |
综合类 | 42篇 |
预防医学 | 81篇 |
眼科学 | 26篇 |
药学 | 104篇 |
中国医学 | 1篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 7篇 |
2022年 | 12篇 |
2021年 | 18篇 |
2020年 | 14篇 |
2019年 | 27篇 |
2018年 | 31篇 |
2017年 | 11篇 |
2016年 | 25篇 |
2015年 | 31篇 |
2014年 | 32篇 |
2013年 | 66篇 |
2012年 | 47篇 |
2011年 | 54篇 |
2010年 | 59篇 |
2009年 | 74篇 |
2008年 | 60篇 |
2007年 | 101篇 |
2006年 | 61篇 |
2005年 | 77篇 |
2004年 | 53篇 |
2003年 | 54篇 |
2002年 | 41篇 |
2001年 | 37篇 |
2000年 | 54篇 |
1999年 | 46篇 |
1998年 | 96篇 |
1997年 | 99篇 |
1996年 | 106篇 |
1995年 | 64篇 |
1994年 | 64篇 |
1993年 | 65篇 |
1992年 | 13篇 |
1991年 | 37篇 |
1990年 | 28篇 |
1989年 | 50篇 |
1988年 | 42篇 |
1987年 | 49篇 |
1986年 | 29篇 |
1985年 | 46篇 |
1984年 | 20篇 |
1983年 | 18篇 |
1982年 | 27篇 |
1981年 | 23篇 |
1980年 | 33篇 |
1979年 | 9篇 |
1978年 | 13篇 |
1977年 | 17篇 |
1976年 | 26篇 |
1975年 | 16篇 |
1970年 | 2篇 |
排序方式: 共有2092条查询结果,搜索用时 15 毫秒
1.
2.
T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment 总被引:1,自引:0,他引:1
A Vidaller L Llorente F Larrea J P Mendez J Alcocer-Varela D Alarcon-Segovia 《Clinical immunology and immunopathology》1986,38(3):337-343
We studied four patients with tumoral hyperprolactinemia and normal ovarian function before and after prolactine levels had become normal with treatment with bromocriptine (BrC), a dopamine agonist that inhibits prolactin release. Their proliferative responses to concanavalin A, pokeweed mitogen, and, to a lesser extent, phytohemagglutinin, their spontaneous and concanavalin A-induced suppression, and their production of interleukin 2 were found to be decreased and to correct partially or completely after bromocriptine treatment. The T-cell response to interleukin 2 was low in two patients in whom it increased after BrC treatment. These findings give insight on the immunomodulatory role of prolactin in vivo. 相似文献
3.
Summary— To investigate if the functional alterations observed in resistance arteries of spontaneously hypertensive rats (SHRs) were also present at the coronary level, in vitro experiments were performed in mesenteric resistance arteries (MRA) and in right (RIC) and left interventricular coronary (LIC) arteries taken from 15–25-week-old SHR and age-matched Wistar Kyoto rats WKYs. Using a passive extension protocol, internal diameters corresponding to 100 mmHg intraluminal pressure (D100) were determined and vessels were set up to a normalized internal diameter (0.9 D100). SHR mesenteric resistance arteries had a significantly smaller diameter compared to WKY arteries, whereas both types of SHR coronary arteries had a greater diameter compared to those of WKY rats. In arteries in the absence of contracting agonist, nitro-L-arginine (NOLA, 100 μM) induced a progressive rise in basal tone, which could be reversed by subsequent addition of L-arginine (100 μM) but not D-arginine (100 μM). When expressed as percent of maximal contractions induced by agonists (noradrenaline, NA [10 μM] in MRA; serotonin, 5-HT [10 μM], in RIC and LIC), these contractions were significantly stronger in WKY compared to SHR coronary and mesenteric resistance arteries. In NA-precontracted MRA and 5HT-precontracted coronary arteries in the presence of indomethacin (10 μM), the magnitude of acetylcholine-induced maximal relaxations (expressed as percent of maximal contractions induced by agonists) was greater in WKY compared to SHR arteries. After a 30-min incubation period, NOLA (100 μM) completely inhibited relaxations induced by acetylcholine (0.01–10 μM) in all types of precontracted arteries. Subsequent additions of sodium nitroprusside, (SNP, 10 μM) induced complete relaxations in all preparations. These results show that a basal release of NO or NO-like compound by endothelial cells is present in isolated mesenteric resistance and coronary arteries of WKY rats and SHRs. The contribution of endothelium-derived relaxing factor-nitric oxide (EDRF-NO) to arterial tone was lower in MRA compared to coronary arteries in both strains and in SHR compared to WKY arteries. In the SHR preparations, the impaired relaxation induced by acetylcholine appeared to be due to a functional alteration of the endothelium in the presence of normal reactivity of the smooth muscle cells. 相似文献
4.
5.
6.
7.
表小檗碱对α受体的作用 总被引:2,自引:0,他引:2
表小檗碱(epiberberine,EB)是从湖北产黄连(Coptis chinensis Franch)中提取的一种生物碱,属苯喹嗪类原小檗碱,对其药理作用的研究资料甚少,未见其对α肾上腺素体作用的报道。资料表明,许多原小檗碱类化合物有α受体阻滞作用,为从该类化合物中选择 相似文献
8.
9.
Antonio Vidaller Fernando Guadarrama Luis Llorente Juan Pablo Méndez Fernando Larrea Antonio R. Villa Donato Alarcón-Segovia 《Journal of clinical immunology》1992,12(3):210-215
We studied NK cell function in eight patients with pathological hyperprolactinemia by measuring51Cr release by K562 cells exposed to their mononuclear cells and found it decreased compared to normal controls (P<0.01). Bromocriptine (BrC) treatment corrected NK function but also made it more efficient at 12:1 than at 25:1 or 50:1 effector:target ratios (ANOVA;P=0.01). The study of NK cell function in agarose revealed that its decrease in hyperprolactinemia is due to their low active binding to target cells, active killing, and recycling capacity. BrC tended to correct them but also increased recycling capacity to levels higher than those of controls (P<0.05). Sequential studies in three hyperprolactinemic patients before and after BrC showed correction of NK function within 1 week but its increased efficiency at the 12:1 effector:target ratio required 8 weeks. We conclude that hyperprolactinemia decreases NK cell function. BrC corrects this by decreasing prolactin levels but also makes NK function more efficient by increasing the capacity of NK cells to recycle after killing. 相似文献
10.